Challenges and Future Opportunities in Rare Genetic Disorders: A Comprehensive Review

Rare genetic disorders (RGDs) are a large and diverse group of diseases with low frequency but great clinical and genetic variation. These illnesses collectively affect millions of individuals globally. Genomic and personalised medicine have illuminated RGD aetiology, but many problems and potentials remain. This review discusses RGD challenges, future opportunities and highlights opportunities to improve patient care and research. Patients often face an odyssey to diagnose RGDs. Clinicians sometimes lack experience or cannot obtain diagnostic tools due to the illnesses’ rarity and overlapping symptoms. Primary care practitioners’ lack of RGD understanding and centralised databases can delay or misdiagnose patients. Due to their limited incidence, RGDs are not economically viable for therapeutic development. Pharmaceutical companies may avoid treating certain illnesses due to high development costs and little commercial potential. Next-generation sequencing (NGS) has greatly shortened diagnosis time. Genome or exome sequencing can discover causative mutations even in rare or undiagnosed illnesses. This technology and global collaborative networks like the Undiagnosed Diseases Network (UDN) will help many patients end their diagnostic journey. Personalised medicine and tailored therapeutics offer promising RGD treatments. CRISPR/Cas9 gene editing targets genetic abnormalities, allowing for potential treatments. Drug repurposing is a cheap technique to uncover RGD medicines without the lengthy and expensive drug development procedure. Patient advocacy and community research are also rising. Patient organisations fundraise, collaborate on research, and influence policy. More empowered communities fight for patient-centric research and care. In conclusion, RGDs face many hurdles, but technological advances, patient advocacy, and collaborative research give hope. RGDs can be solved using cutting-edge technologies, interdisciplinary cooperation and a patient-centred approach.